Withings, Babyscripts Team Up to Tackle Hypertensive Disorders of Pregnancy – MedCity News
Through a new partnership, Babyscripts members now have access to Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor.
Related Articles
Priority Health Taps Ayble Health to Address GI Disorders – MedCity News
Through a new partnership, Priority Health members will be able to receive virtual gastrointestinal care from Ayble Health.
Startup HAYA Hauls In $65M to Shed Light on the Dark Genome With a Lead Drug for Heart Failure – MedCity News
HAYA Therapeutics’ drugs hit targets in the dark genome, the part of the genome that does not code for proteins but plays a key role…
FDA Approves First At-Home Cervical Cancer Test – MedCity News
Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The…
9 Ways to Find Caregivers With Flexible Scheduling Options – MedCity News
Discover nine top caregiver services with flexible scheduling to fit changing routines, shift work or evolving health needs — featuring trusted platforms and in-home care…
AI’s Next Act: New Medicines – MedCity News
We may be on the eve of the next breakthrough: a new combination of “old” algorithms that promises to radically accelerate the discovery and development…
Patient-Centricity is Reliant on Representative Clinical Studies – MedCity News
Recent FDA guidance aims to improve research inclusivity and the generalizability of clinical findings by ensuring diverse participant representation — it’s about better science, improved…
Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? – MedCity News
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to…
Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer – MedCity News
Verastem Oncology developed its drug combination for low-grade serous ovarian cancer (LGSOC) driven by KRAS mutations. As the first treatment specifically approved for this rare…
Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer – MedCity News
Verastem Oncology developed its drug combination for low-grade serous ovarian cancer (LGSOC) driven by KRAS mutations. As the first treatment specifically approved for this rare…
Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? – MedCity News
Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to…